CORRECTED - CORRECTED-BRIEF-FDA approves new indication for Wyeth skin-infec

martes 24 de marzo de 2009 17:57 CET
 

(Corrects headline to show that the drug is a skin-infection drug and not a pneumonia drug)

March 24 (Reuters) - Wyeth WYE.N: * FDA approves new indication for Wyeth's Tygacil (tigecycline) for the treatment of adult patients with community-acquired bacterial pneumonia * Says FDA okays Tygacil to treat community-acquired bacterial pneumonia